Table 2.
Comparison of the clinicopathological factors in patients with or without HT
|
Total patients (5115) |
|
Patients with HT (628) |
|
Patients with Benign disease(2495) |
|
|||
---|---|---|---|---|---|---|---|---|---|
With HT | Without HT | P value | HT with PTC | HT without PTC | P value | Benign with HT | Benign without HT | P value | |
Number of patients |
628(12.28%) |
4487(87.72%) |
|
358(57.00%) |
270(43.00%) |
|
270 |
2225 |
|
Age (years) |
44.35±11.99 |
46.28±12.27 |
0.001 |
42.64±12.04 |
46.62±11.56 |
0.001 |
46.62±11.56 |
48.38±12.35 |
0.018 |
Female |
573 |
3248 |
0.001 |
330 |
243 |
0.339 |
243 |
1608 |
0.001 |
Nodule size (cm) |
1.81±1.23 |
2.32±1.50 |
0.001 |
1.21±0.90 |
2.44±1.32 |
0.001 |
2.64±1.32 |
3.33±1.34 |
0.001 |
TSH | 2.82±2.38 | 2.22±1.90 | 0.001 | 3.26±2.54 | 2.23±2.02 | 0.001 | 2.23±2.02 | 1.91±2.03 | 0.025 |
*:All the patients in the table had serum TSH test.